• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多西他赛诱导激素难治性前列腺癌细胞发生有丝分裂灾难和凋亡。

Mitotic catastrophe and apoptosis induced by docetaxel in hormone-refractory prostate cancer cells.

作者信息

Fabbri Francesco, Amadori Dino, Carloni Silvia, Brigliadori Giovanni, Tesei Anna, Ulivi Paola, Rosetti Marco, Vannini Ivan, Arienti Chiara, Zoli Wainer, Silvestrini Rosella

机构信息

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.), Meldola (FC), Italy.

出版信息

J Cell Physiol. 2008 Nov;217(2):494-501. doi: 10.1002/jcp.21522.

DOI:10.1002/jcp.21522
PMID:18615564
Abstract

Studies performed in different experimental and clinical settings have shown that Docetaxel (Doc) is effective in a wide range of tumors and that it exerts its activity through multiple mechanisms of action. However, the sequence of events induced by Doc which leads to cell death is still not fully understood. Moreover, it is not completely clear how Doc induces mitotic catastrophe and whether this process is an end event or followed by apoptosis or necrosis. We investigated the mechanisms by which Doc triggers cell death in hormone-refractory prostate cancer cells by analyzing cell cycle perturbations, apoptosis-related marker expression, and morphologic cell alterations. Doc induced a transient increase in G2/M phase followed by the appearance of G0/1 hypo- and hyperdiploid cells and increased p21 expression. Time- and concentration-dependent apoptosis was induced in up to 70% of cells, in concomitance with Bcl-2 phosphorylation, which was followed by caspase-2 and -3 activation. In conclusion, Doc would seem to trigger apoptosis in hormone-refractory prostate cancer cells via mitotic catastrophe through two forms of mitotic exit, in concomitance with increased p21 expression and caspase-2 activation.

摘要

在不同实验和临床环境中进行的研究表明,多西他赛(Doc)对多种肿瘤有效,且通过多种作用机制发挥其活性。然而,Doc诱导导致细胞死亡的一系列事件仍未完全明了。此外,Doc如何诱导有丝分裂灾难以及该过程是终末事件还是继之以凋亡或坏死也不完全清楚。我们通过分析细胞周期扰动、凋亡相关标志物表达及细胞形态改变,研究了Doc在激素难治性前列腺癌细胞中触发细胞死亡的机制。Doc诱导G2/M期短暂增加,随后出现G0/1亚二倍体和超二倍体细胞,并增加p21表达。高达70%的细胞诱导出时间和浓度依赖性凋亡,同时伴有Bcl-2磷酸化,随后是caspase-2和-3激活。总之,Doc似乎通过有丝分裂灾难,经由两种有丝分裂退出形式,在激素难治性前列腺癌细胞中触发凋亡,同时伴有p21表达增加和caspase-2激活。

相似文献

1
Mitotic catastrophe and apoptosis induced by docetaxel in hormone-refractory prostate cancer cells.多西他赛诱导激素难治性前列腺癌细胞发生有丝分裂灾难和凋亡。
J Cell Physiol. 2008 Nov;217(2):494-501. doi: 10.1002/jcp.21522.
2
Docetaxel loaded oleic acid-coated hydroxyapatite nanoparticles enhance the docetaxel-induced apoptosis through activation of caspase-2 in androgen independent prostate cancer cells.载多西紫杉醇的油酸包覆的羟基磷灰石纳米颗粒通过激活 caspase-2 增强多西紫杉醇诱导的雄激素非依赖性前列腺癌细胞凋亡。
J Control Release. 2010 Oct 15;147(2):278-88. doi: 10.1016/j.jconrel.2010.07.108. Epub 2010 Jul 23.
3
Suppression of human prostate cancer cell growth by ciprofloxacin is associated with cell cycle arrest and apoptosis.环丙沙星对人前列腺癌细胞生长的抑制作用与细胞周期阻滞和细胞凋亡有关。
Int J Oncol. 2003 Apr;22(4):787-94.
4
Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models.阿扎胞苷可增强多西他赛和顺铂在侵袭性前列腺癌模型中的抗肿瘤作用。
Endocr Relat Cancer. 2009 Jun;16(2):401-13. doi: 10.1677/ERC-08-0130. Epub 2009 Jan 19.
5
Pretreatment of docetaxel enhances TRAIL-mediated apoptosis in prostate cancer cells.多西他赛预处理可增强TRAIL介导的前列腺癌细胞凋亡。
J Cell Biochem. 2008 Aug 1;104(5):1636-46. doi: 10.1002/jcb.21729.
6
Docetaxel-induced prostate cancer cell death involves concomitant activation of caspase and lysosomal pathways and is attenuated by LEDGF/p75.多西他赛诱导的前列腺癌细胞死亡涉及半胱天冬酶和溶酶体途径的同时激活,并被 LEDGF/p75 减弱。
Mol Cancer. 2009 Aug 28;8:68. doi: 10.1186/1476-4598-8-68.
7
Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β.雷洛昔芬通过不同水平的雌激素受体 α 和 β 在表达的前列腺癌细胞中通过多种信号通路诱导细胞死亡并抑制增殖。
J Cell Physiol. 2011 May;226(5):1334-9. doi: 10.1002/jcp.22461.
8
Low dose combinations of 2-methoxyestradiol and docetaxel block prostate cancer cells in mitosis and increase apoptosis.2-甲氧基雌二醇与多西他赛的低剂量组合可使前列腺癌细胞阻滞于有丝分裂期并增加细胞凋亡。
Cancer Lett. 2009 Apr 8;276(1):21-31. doi: 10.1016/j.canlet.2008.10.026. Epub 2008 Nov 28.
9
The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells.新型抗微管药物隐藻素52(LY355703)通过多种途径诱导人前列腺癌细胞凋亡。
Clin Cancer Res. 2002 Dec;8(12):3922-32.
10
Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.吲哚 - 3 - 甲醇(I3C)可诱导前列腺癌细胞的细胞生长抑制、G1期细胞周期阻滞及凋亡。
Oncogene. 2001 May 24;20(23):2927-36. doi: 10.1038/sj.onc.1204365.

引用本文的文献

1
DRG2 levels in prostate cancer cell lines predict response to PARP inhibitor during docetaxel treatment.前列腺癌细胞系中的DRG2水平可预测多西他赛治疗期间对PARP抑制剂的反应。
Investig Clin Urol. 2025 Jan;66(1):56-66. doi: 10.4111/icu.20240263.
2
Curcumin and Its Potential to Target the Glycolytic Behavior of Lactate-Acclimated Prostate Carcinoma Cells with Docetaxel.姜黄素及其与多西他赛共同靶向乳酸适应型前列腺癌细胞糖酵解行为的潜力。
Nutrients. 2024 Dec 16;16(24):4338. doi: 10.3390/nu16244338.
3
Key genes and molecular mechanisms related to Paclitaxel Resistance.
与紫杉醇耐药相关的关键基因和分子机制。
Cancer Cell Int. 2024 Jul 13;24(1):244. doi: 10.1186/s12935-024-03415-0.
4
Information-Distilled Generative Label-Free Morphological Profiling Encodes Cellular Heterogeneity.信息提取的生成式无标记形态分析编码细胞异质性。
Adv Sci (Weinh). 2024 Aug;11(29):e2307591. doi: 10.1002/advs.202307591. Epub 2024 Jun 12.
5
Capivasertib combines with docetaxel to enhance anti-tumour activity through inhibition of AKT-mediated survival mechanisms in prostate cancer.卡培他滨与多西他赛联合应用通过抑制 AKT 介导的前列腺癌细胞存活机制增强抗肿瘤活性。
Br J Cancer. 2024 May;130(8):1377-1387. doi: 10.1038/s41416-024-02614-w. Epub 2024 Feb 23.
6
GAD1 contributes to the progression and drug resistance in castration resistant prostate cancer.GAD1促进去势抵抗性前列腺癌的进展和耐药性。
Cancer Cell Int. 2023 Oct 30;23(1):255. doi: 10.1186/s12935-023-03093-4.
7
Tumor Treating Fields (TTFields) Therapy Concomitant with Taxanes for Cancer Treatment.肿瘤电场(TTFields)疗法联合紫杉烷类药物用于癌症治疗。
Cancers (Basel). 2023 Jan 19;15(3):636. doi: 10.3390/cancers15030636.
8
Docetaxel Resistance in Castration-Resistant Prostate Cancer: Transcriptomic Determinants and the Effect of Inhibiting Wnt/β-Catenin Signaling by XAV939.多西他赛耐药的去势抵抗性前列腺癌:转录组学决定因素及 XAV939 抑制 Wnt/β-连环蛋白信号的作用。
Int J Mol Sci. 2022 Oct 25;23(21):12837. doi: 10.3390/ijms232112837.
9
Androgen Flare after LHRH Initiation Is the Side Effect That Makes Most of the Beneficial Effect When It Coincides with Radiation Therapy for Prostate Cancer.促黄体生成素释放激素(LHRH)开始使用后出现的雄激素波动是一种副作用,当它与前列腺癌放射治疗同时发生时,这种副作用在很大程度上产生了有益效果。
Cancers (Basel). 2022 Apr 13;14(8):1959. doi: 10.3390/cancers14081959.
10
Administering Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer 1-6 Days Compared to More Than 14 Days after the Start of LHRH Agonist Is Associated with Better Clinical Outcomes Due to Androgen Flare.与在促黄体生成素释放激素(LHRH)激动剂开始使用超过14天后给药相比,在开始使用LHRH激动剂1 - 6天内给予多西他赛治疗转移性激素敏感性前列腺癌,由于雄激素激增,临床结局更佳。
Cancers (Basel). 2022 Feb 9;14(4):864. doi: 10.3390/cancers14040864.